LYNCH TIMOTHY P → AEON Biopharma, Inc. AEON

Stake: — Shares: — Class: Class A Common Stock

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

1 transaction

1 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-07-31

DTC 1.00

876,967 shares short · -21.2% vs prior

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-08-19	LYNCH TIMOTHY P	10%+ owner	Buy	1,150,000	$0.21	$243K

Other 13D/G Filings on AEON Biopharma, Inc.

Filed	Form	Filer	Stake	Shares
2026-07-21	SCHEDULE 13G	Stonepine Capital Management, LLC	—	—	view →
2026-01-29	SCHEDULE	Daewoong Co., Ltd	90.00%	91,357	view →
2025-03-07	SCHEDULE	PALMISANO ROBERT J	5.70%	2,265,000	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →